Issue Date: December 4, 2017 | Web Date: November 30, 2017
Chemists engineer bacteria to use unnatural DNA bases to make unnatural proteins
The genome of every cell on Earth uses four DNA bases—adenine, thymine, cytosine, and guanine—to encode proteins. Chemists have long dreamed of expanding that set to create cells that work with both natural and unnatural nucleic acids. An expanded collection of bases could allow cells to synthesize unnatural amino acid-containing proteins that have new functions and could be useful as novel drugs, vaccines, and nanomaterials. But the closest researchers had gotten was to translate DNA with expanded base sets into proteins in test tubes.
Now, Floyd E. Romesberg of Scripps Research Institute California and coworkers have gone all the way by putting an expanded genetic code into bacteria and getting the microbes to use it to synthesize an unnatural protein (Nature 2017, DOI: 10.1038/nature24659).
The researchers got a strain of Escherichia coli to work with dNaM and dTPT3, aromatic DNA bases that pair with each other through complementary packing and hydrophobic forces instead of the usual hydrogen bonding that natural bases use. They engineered the bacteria with a circular DNA plasmid that had a gene for green fluorescent protein (GFP). Inside that gene, the researchers inserted the unnatural base pair dNaM-dTPT3 at a site where they wanted to incorporate an unnatural amino acid in GFP.
The scientists modified the bacteria to express an enzyme that transcribes the GFP gene to a messenger RNA with the RNA version of NaM at the corresponding site. To allow the bacteria to translate mRNA containing this unnatural base, the researchers also engineered the cells to produce a transfer RNA that could recognize NaM. During protein translation, in general, a three-base anticodon in a tRNA binds to a three-base codon in an mRNA, causing the ribosome to add an amino acid that is bound to the tRNA to the growing protein chain. In the new study, the engineered tRNA contained the RNA version of TPT3 in its anticodon to pair with NaM in the mRNA.
The scientists tested the system with two different tRNAs, each carrying a different unnatural amino acid—an N-propargyl-lysine or p-azido-phenylalanine—and demonstrated that the bacteria added each at the proper spot in GFP. Romesberg earlier cofounded the biotech firm Synthorx to commercialize this type of expanded-DNA technology.
The work shows that unnatural base pairs are compatible with the molecular biological machinery inside cells, “opening the door to a new stage of genetic alphabet expansion,” comments Ichiro Hirao of A-STAR Institute of Bioengineering & Nanotechnology.
Steven A. Benner of the Foundation for Applied Molecular Evolution is skeptical of how broadly applicable this technology is. He believes hydrophobic base pairing may work only when unnatural bases are sandwiched between natural ones for stabilization, and he doubts this type of base pairing is a credible system for sustaining varied forms of semisynthetic life.
On the other hand, Dieter Söll of Yale University thinks the work has great promise. “It is the first real proof that living things will be able to make customized proteins with multiple unnatural amino acids in the future,” he says.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society